Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Dexmedetomidine for PTSD Prevention in Brain Surgery
NCT06498700Enrolling by invitation
- Sponsor
- Zagazig University
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Zagazig University. Primary endpoint: Post-traumatic Stress Disorder at 6 months. Started Jul 2024; status: enrolling by invitation.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06498700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06498700.